Growth as a manifestation of teratogenesis: Lessons from human fetal pathology

Reproductive Toxicology

Volumn 11, Issue 4, 1997, Pages 583-587

  Barr Jr , Mason ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPSY; BLOOD TRANSFUSION REACTION; CONGENITAL MALFORMATION; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; FETUS MALFORMATION; HUMAN; HYPOTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY; KIDNEY AGENESIS; NEWBORN ANEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; REVIEW; TERATOGENESIS; TRISOMY; TURNER SYNDROME;

EID: 0031195319     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)89177-0     Document Type: Article

References (31)

1. 1. Brent RL, Jensh RP. Intrauterine growth retardation. In Woollam DHM, ed. Advances in teratology, vol. 2. London: Logos Press; 1967:139-227.
2. 2. Barr M, Jensh RP, Brent RL. Fetal weight and intrauterine position in rats. Teratology. 1969;2:231-46.
3. 3. Barr M, Jensh RP, Brent RL. Prenatal growth in the albino rat: effect of number, intrauterine position and resorptions. Am J Anat. 1970;128:413-28.
4. 4. Jensh RP, Brent RL, Barr M. The litter effect as a variable in teratologic studies of the albino rat. Am J Anat. 1970;128:185-92.
5. 5. Shepard TH, Shi M, Fellingham GW, Fujinaga M, Fitzsimmons JM, Fantel AG, Barr M. Organ weight standards for human fetuses. Pediatr Pathol. 1988;8:513-24.
6. 6. Barr M, Blackburn WR, Cooley NR. Human fetal somatic and visceral morphometrics. Teratology. 1994;49:487-96.
7. 7. Alexander GR, Allen MC. Conceptualization, measurement, and use of gestational age. I. Clinical and public health practice. J Perinatol. 1996;16:53-9.
8. 8. Barr M. Use of the last menstrual period (LMP) in timing human pregnancies. Teratology. 1981;23:134.
9. 9. Hartshorne N, Shepard T, Barr M. Compensatory renal growth in human fetuses with unilateral renal agenesis. Teratology. 1991;44: 7-10.
10. 10. Barr M. Amniotic volume and fetal renal weight. Teratology. 1987;35:67A-68A.
11. 11. Pryde PG, Sedman AB, Nugent CE, Barr M. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol. 1993;3:1575-82.
12. 12. Martin RA, Jones KL, Mendoza A, Barr M, Benirschke K. The effect of ACE inhibition on the fetal kidney: decreased renal blood flow. Teratology. 1992;46:317-21.
13. 13. Pridjian G, Nugent CE, Barr M. Twin gestation: influence of placentation on fetal growth. Am J Obstet Gynecol. 1991;165: 1394-401.
14. 14. Barr M. Twin growth profiles and identification of twin-twin transfusion in midgestation. Proc Greenwood Genet Ctr. 1996;15: 151-2.
15. 15. Barr M, Oman-Ganes L. Subnormal heart weight and hydropic Turner syndrome in midgestation: a cause of death. Proc Greenwood Genet Ctr. 1989;8:169.
16. 16. Barr M. Cardiac hypoplasia as a primary defect and cause of death in Turner syndrome fetuses. Proc Greenwood Genet Ctr. 1994;13: 61-2.
17. 17. Barr M. Growth profiles of human autosomal trisomies at midgestation. Teratology. 1994;50:395-8.
18. 18. Cuckle H, Wald N, Quinn J, Royston P, Butler L. Ultrasound fetal femur length measurement in the screening for Down's syndrome. Br J Obstet Gynaecol. 1989;96:1373-8.
19. 19. Fitzsimmons J, Droste S, Shepard TH, Pascoe-Mason J, Chinn A, Mack LA. Long-bone growth in fetuses with Down syndrome. Am J Obstet Gynecol. 1989;161:1174-7.
20. 20. Rodis JF, Vintizileos AM, Fleming AD, Ciarleglio L, Nardi A, Feeney L, Scorza WE, Campbell WA, Ingardia C. Comparison of humerus length with femur length in fetuses with Down syndrome. Am J Obstet Gynecol. 1991;165:1051-6.
21. 21. Benacerraf BR, Neuberg D, Frigoletto FD. Humeral shortening in second-trimester fetuses with Down syndrome. Obstet Gynecol. 1991;77:223-7.
22. 22. Rotmensch S, Luo JS, Liberati M, Belanger K, Mahoney MJ, Hobbins JC. Fetal humeral length to detect Down syndrome. Am J Obstet Gynecol. 1992;166:1330-4.
23. 23. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Williams MA. Humerus and femur length shortening in the detection of Down syndrome. Am J Obstet Gynecol. 1993;168:534-8.
24. 24. Johnson MP, Barr M, Evans MI. Third trimester progression of aneuploid-specific aberrant growth patterns of trisomy 21. Am J Hum Genet. 1990;47:A278.
25. 25. Johnson MP, Barr M, Treadwell MC, Michaelson J, Isada NB, Pryde PG, Dombrowski MP, Cotton DB, Evans MI. Fetal leg and femur:foot length ratio: a marker for trisomy 21. Am J Obstet Gynecol. 1993;169:557-63.
26. 26. Johnson MP, Michaelson JE, Barr M, Treadwell MC, Isada NB, Dombrowski MP, Pryde PG, Addis J, Evans MI. Sonographic screening for trisomy 21: fetal humerus:foot length ratio, a useful new marker. Fetal Diagn Therapy. 1994;9:130-8.
27. 27. Johnson MP, Michaelson JE, Barr M, Treadwell MC, Hume RF, Dombrowski MP, Johnson A, Bichalski J, Evans MI. Combining humerus and femur length for improved sonographic identification of pregnancies at increased risk for trisomy 21. Am J Obstet Gynecol. 1995;172:1229-35.
28. 28. Johnson MP, Barr M, Qureshi F, Drugan A, Evans MI. Symmetrical intrauterine growth retardation is not symmetrical: organ-specific gravimetric deficits in midtrimester and neonatal trisomy 18. Fetal Therapy. 1989;4:110-9.
29. 29. Rushton DI. The nature and causes of spontaneous abortion with normal karyotypes. In H Kalter, ed. Issues and reviews in teratology, vol. 3. New York: Plenum Press; 1985:21-63.
30. 30. Hook EB. Genetic counseling and prenatal cytogenetic services: policy implications and detailed cost-benefit analyses of programs for the prevention of Down syndrome. In Porter IH, Hook EB, eds. Service and education in medical genetics. San Diego: Academic Press; 1979:29-54.
31. 31. Warkany J. Terathanasia. Teratology. 1978;17:187-92.